| Award Mechanism |
Eligibility |
Key Mechanism Elements |
Funding |
| Concept Award (to be offered in April 2010) |
Investigators at all academic levels (or equivalent) |
- Supports the exploration of a highly innovative new concept or untested theory that addresses an
important problem relevant to breast cancer
- Supports high-risk studies that have the potential to reveal new avenues for investigation
- Preliminary data not allowed
|
- Maximum funding of $75K for direct costs (plus indirect costs)
- Period of performance not to exceed 1 year
|
| Era of Hope Scholar Award |
Independent, non-mentored investigators within 6 years of their last mentored position as of the application
submission deadline |
- Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the
"best and brightest" in their fields
- Individuals should exhibit strong potential for leadership in the breast cancer community
|
- Maximum funding of $2.5M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
| Idea Award |
- Investigators at all academic levels (or equivalent)
- Postdoctoral-level investigators are eligible and are encouraged to apply
|
- Supports conceptually innovative, high-risk/high-reward research from all areas of basic, translational,
clinical, behavioral, and epidemiological research
- Innovation is the most important review criterion
- Preliminary data not consistent with intent of the award mechanism; strength of proposal should not rely
on preliminary data
- Collaborative Option supports combining expertise of two Principal Investigators to more effectively
address an innovative research question
|
- Maximum funding of $375K for direct costs (plus indirect costs) Period of performance not to exceed 2 years
- For Collaborative Option: Maximum funding of $550K for direct costs (plus indirect costs) Period of
performance not to exceed 2 years
- For Population-Based Studies: Maximum funding of $750K for direct costs (plus indirect costs) Period of
performance not to exceed 4 years
|
| Innovator Award |
Associate Professor or above (or equivalent) |
- Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any
field
- Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the
eradication of breast cancer
|
- Maximum funding of $5M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
| Inter-Institutional Training Award |
- Principal Investigator/Co-investigator(s): Faculty members with doctoral degrees who are at an
institution that does not have an established breast cancer research program
- Mentor(s): Must be part of an established breast cancer research program at the mentoring institution
|
- Supports two or more faculty-level investigators at an organization that does not currently have a breast
cancer research program to acquire mentored training in breast cancer research
- Supports the establishment of a sustainable breast cancer research program at the applicant organization
- Proposed research and training should lead to publication(s) and independent breast cancer research funding
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $1M for direct costs (plus indirect costs)
- Period of performance not to exceed 4 years
|
| Multi-Team Award |
- Three independent, faculty-level (or equivalent) investigators
- Must include a basic investigator, a clinical investigator, and an investigator from any other area of
expertise
|
- Supports three innovative investigators and their research teams in a coordinated and integrated
translational research effort to address a question of major importance in breast cancer
- Teams must include consumer advocates
- Multiple institutions must be involved
- A clear plan for intensive collaboration among the teams must be demonstrated
- Regular in-person meetings and on-site cross-training of investigators among the research teams will be
required
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $300K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Postdoctoral Fellowship Award |
- Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program
- No more than 2 years in the proposed research setting and no more than 4 years' postdoctoral research
experience
- Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications
|
- Supports the training of exceptionally talented recent doctoral graduates
- Proposed research should be innovative and have the potential for high impact
- Multidisciplinary training encouraged
- Training program and mentorship should prepare the PI for an independent career at the forefront of
breast cancer research
|
- Maximum funding of $300K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Predoctoral Traineeship Award |
- Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program
- Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications
|
- Supports the training of promising graduate students studying breast cancer research under the guidance
of a designated mentor
- The predoctoral trainee is considered the PI and should write the proposal with appropriate direction from the mentor
- Training program and mentorship should facilitate development of the PI as a breast cancer researcher
|
- Maximum funding of $120K for direct costs (plus indirect costs)
- Period of performance not to exceed 3 years
|
| Transformative Vision Award |
Investigators at all academic levels (or equivalent) |
- Supports research programs that have an extraordinary vision for dramatically transforming the prevention or
treatment of breast cancer and a plan to test and implement the vision as quickly as possible
- Focuses on achieving a visionary solution to a problem or question of overarching importance to breast
cancer through an investigator-defined approach
- Preproposal is required; proposal submission is by invitation only
|
- Maximum funding of $12M for direct costs (plus indirect costs)
- Period of performance not to exceed 5 years
|
All applications must conform to the final program announcements and application instructions that will be
available for electronic downloading from the Grants.gov website. The application package containing the required
forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can
be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website
(http://cdmrp.org) prior to application submission. Applications must be submitted
through the federal government's single-entry portal, Grants.gov. Requests for
email notification of the program announcements release may be sent to help@cdmrp.org.
For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website
(http://cdmrp.army.mil).
Point of Contact:
